Chip Stocks Plummet, Broadcom Falls Over 15%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: stocktwits
- Broadcom Disappointment: Broadcom's stock plummeted over 15% after failing to raise AI revenue expectations for fiscal years 2026 and 2027, which disappointed investors and raised concerns about future growth prospects.
- Semiconductor ETFs Decline: The VanEck Semiconductor ETF fell approximately 3%, while the iShares Semiconductor ETF dropped 4%, indicating weakness across the semiconductor sector that could impact financing and investment decisions for related companies.
- Healthcare Stocks Surge: UnitedHealth Group's shares rose nearly 6% after BofA upgraded its rating from 'Neutral' to 'Buy', raising the price target from $420 to $450, highlighting the strong recovery potential in the healthcare sector.
- Crude Oil Prices Cool: U.S. West Texas Intermediate crude futures declined 3.48% to around $92.68 per barrel, reflecting market concerns over demand outlook, which may also affect the performance of energy-related stocks.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 377.000
Low
330.00
Averages
397.82
High
444.00
Current: 377.000
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UnitedHealth Group Shares Surge 5% on Upgraded Price Targets
- Analyst Target Upgrades: Morgan Stanley analyst Erin Wright raised UnitedHealth's price target from $395 to $453 while maintaining an ‘Overweight’ rating, indicating over 12% upside potential from current levels, reflecting increased market confidence in the healthcare giant.
- Improving Medical Cost Trends: BofA analyst Kevin Fischbeck upgraded UnitedHealth's rating from ‘Neutral’ to ‘Buy’ with a new price target of $450, noting that first-quarter medical cost trends exceeded consensus expectations, which is expected to drive favorable second-quarter performance.
- Shifting Market Sentiment: According to Stocktwits data, retail sentiment around UnitedHealth has shifted from ‘bearish’ to ‘neutral’, with message volumes increasing from ‘low’ to ‘normal’, indicating a recovery in investor confidence regarding the company's future prospects.
- Strong Earnings Report: UnitedHealth reported first-quarter revenue of $111.7 billion, surpassing analyst expectations, while adjusted earnings came in at $7.23 per share, significantly exceeding Wall Street's estimate of $6.61, showcasing the company's robust performance and profitability in the healthcare insurance market.
See More
Mixed US Stock Market with Tech Stocks Under Pressure
- Tech Stock Decline: Broadcom (AVGO) shares plummeted over 15% after its AI revenue forecast fell short, marking it as the largest decliner in the Nasdaq 100, which reflects growing concerns about the tech sector and may dampen investor confidence.
- Weak Employment Data: Initial jobless claims in the US rose by 13,000 to 225,000, reaching a 3.75-month high, indicating a weakening labor market that could lead to downward revisions in growth expectations.
- Healthcare Stocks Strong: UnitedHealth Group (UNH) surged over 6%, leading gains in the S&P 500, after Bank of America upgraded its rating from neutral to buy with a price target of $450, showcasing resilience in the healthcare sector.
- International Market Volatility: European markets showed mixed results, with Eurozone April retail sales falling 0.4% month-over-month, worse than the expected 0.3%, indicating weak consumer spending that could pressure future economic growth.
See More
Chip Stocks Plummet, Broadcom Falls Over 15%
- Broadcom Disappointment: Broadcom's stock plummeted over 15% after failing to raise AI revenue expectations for fiscal years 2026 and 2027, which disappointed investors and raised concerns about future growth prospects.
- Semiconductor ETFs Decline: The VanEck Semiconductor ETF fell approximately 3%, while the iShares Semiconductor ETF dropped 4%, indicating weakness across the semiconductor sector that could impact financing and investment decisions for related companies.
- Healthcare Stocks Surge: UnitedHealth Group's shares rose nearly 6% after BofA upgraded its rating from 'Neutral' to 'Buy', raising the price target from $420 to $450, highlighting the strong recovery potential in the healthcare sector.
- Crude Oil Prices Cool: U.S. West Texas Intermediate crude futures declined 3.48% to around $92.68 per barrel, reflecting market concerns over demand outlook, which may also affect the performance of energy-related stocks.
See More
New Fed Chair Calls for Regime Change
- Impact of Quantitative Tightening: New Fed Chair Kevin Warsh's proposal to shrink the $6.7 trillion balance sheet is expected to implement quantitative tightening through bond sales or maturities, thereby reducing liquidity in financial markets and potentially raising interest rates, which will influence investor decisions.
- Opportunities for Berkshire Hathaway: As of March 31, 2026, Berkshire Hathaway holds over $397 billion in cash and short-term investments, the highest in its history, and if rates rise, it will increase interest income, allowing the company to leverage its cash reserves to acquire quality stocks at lower prices.
- Growth Potential for JPMorgan Chase: JPMorgan Chase anticipates generating $103 billion in interest income this year, and if interest rates rise, its net interest income will likely grow further, potentially attracting customers from smaller banks under competitive pressures, enhancing its market position.
- Advantages for UnitedHealth Group: As the largest health insurer, UnitedHealth Group can benefit from higher interest rates on its float, and despite potential consumer spending cuts, its valuation remains about 40% below its 2024 peak, making it more attractive to investors if Warsh successfully reduces the Fed's balance sheet.
See More
UnitedHealth Group's Earnings Outlook Remains Positive
- Strategic Transformation Success: Bank of America upgraded UnitedHealth Group from neutral to buy and raised its price target from $420 to $450, indicating a 19% upside from Wednesday's close, reflecting the initial success of the company's strategic transformation.
- Enhanced Profitability: Analysts noted that UnitedHealth's earnings power is now 50% above its 2026 outlook, which should drive share price increases, showcasing the company's successful execution in improving margins.
- Positive Market Reaction: UnitedHealth's shares rose 3% in premarket trading, and the stock has jumped nearly 26% over the past year, indicating market recognition of its strategic adjustments and future growth potential.
- Strong Analyst Consensus: Among the 30 analysts covering UnitedHealth, 23 have rated the stock as buy or strong buy, demonstrating a widespread optimistic outlook on its future performance.
See More
Bank of America Upgrades UnitedHealth to Buy Amid Positive Q2 Outlook
- Rating Upgrade: Bank of America upgraded UnitedHealth Group (UNH) from Neutral to Buy, primarily based on an optimistic outlook for Q2 earnings, indicating a resurgence of market confidence in the company.
- Improved Earnings Outlook: Analyst Kevin Fischbeck noted that UnitedHealth's strong Q1 performance was not solely due to lower medical utilization from flu and storms, but rather reflects more favorable medical cost trends, suggesting significant Q2 earnings potential.
- Price Target Increase: BofA raised its price target for UnitedHealth from $420 to $450, indicating enhanced analyst confidence in the company's future performance, which is expected to bolster its leadership position in the healthcare sector.
- Industry Influence: As a bellwether in the healthcare industry, UnitedHealth's performance is likely to impact other managed care organizations (MCOs), with analysts suggesting that if current trends persist, the company will lead its peers higher.
See More
UnitedHealth Group Shares Surge 5% on Upgraded Price Targets
- Analyst Target Upgrades: Morgan Stanley analyst Erin Wright raised UnitedHealth's price target from $395 to $453 while maintaining an ‘Overweight’ rating, indicating over 12% upside potential from current levels, reflecting increased market confidence in the healthcare giant.
- Improving Medical Cost Trends: BofA analyst Kevin Fischbeck upgraded UnitedHealth's rating from ‘Neutral’ to ‘Buy’ with a new price target of $450, noting that first-quarter medical cost trends exceeded consensus expectations, which is expected to drive favorable second-quarter performance.
- Shifting Market Sentiment: According to Stocktwits data, retail sentiment around UnitedHealth has shifted from ‘bearish’ to ‘neutral’, with message volumes increasing from ‘low’ to ‘normal’, indicating a recovery in investor confidence regarding the company's future prospects.
- Strong Earnings Report: UnitedHealth reported first-quarter revenue of $111.7 billion, surpassing analyst expectations, while adjusted earnings came in at $7.23 per share, significantly exceeding Wall Street's estimate of $6.61, showcasing the company's robust performance and profitability in the healthcare insurance market.
See More
Mixed US Stock Market with Tech Stocks Under Pressure
- Tech Stock Decline: Broadcom (AVGO) shares plummeted over 15% after its AI revenue forecast fell short, marking it as the largest decliner in the Nasdaq 100, which reflects growing concerns about the tech sector and may dampen investor confidence.
- Weak Employment Data: Initial jobless claims in the US rose by 13,000 to 225,000, reaching a 3.75-month high, indicating a weakening labor market that could lead to downward revisions in growth expectations.
- Healthcare Stocks Strong: UnitedHealth Group (UNH) surged over 6%, leading gains in the S&P 500, after Bank of America upgraded its rating from neutral to buy with a price target of $450, showcasing resilience in the healthcare sector.
- International Market Volatility: European markets showed mixed results, with Eurozone April retail sales falling 0.4% month-over-month, worse than the expected 0.3%, indicating weak consumer spending that could pressure future economic growth.
See More
Chip Stocks Plummet, Broadcom Falls Over 15%
- Broadcom Disappointment: Broadcom's stock plummeted over 15% after failing to raise AI revenue expectations for fiscal years 2026 and 2027, which disappointed investors and raised concerns about future growth prospects.
- Semiconductor ETFs Decline: The VanEck Semiconductor ETF fell approximately 3%, while the iShares Semiconductor ETF dropped 4%, indicating weakness across the semiconductor sector that could impact financing and investment decisions for related companies.
- Healthcare Stocks Surge: UnitedHealth Group's shares rose nearly 6% after BofA upgraded its rating from 'Neutral' to 'Buy', raising the price target from $420 to $450, highlighting the strong recovery potential in the healthcare sector.
- Crude Oil Prices Cool: U.S. West Texas Intermediate crude futures declined 3.48% to around $92.68 per barrel, reflecting market concerns over demand outlook, which may also affect the performance of energy-related stocks.
See More
New Fed Chair Calls for Regime Change
- Impact of Quantitative Tightening: New Fed Chair Kevin Warsh's proposal to shrink the $6.7 trillion balance sheet is expected to implement quantitative tightening through bond sales or maturities, thereby reducing liquidity in financial markets and potentially raising interest rates, which will influence investor decisions.
- Opportunities for Berkshire Hathaway: As of March 31, 2026, Berkshire Hathaway holds over $397 billion in cash and short-term investments, the highest in its history, and if rates rise, it will increase interest income, allowing the company to leverage its cash reserves to acquire quality stocks at lower prices.
- Growth Potential for JPMorgan Chase: JPMorgan Chase anticipates generating $103 billion in interest income this year, and if interest rates rise, its net interest income will likely grow further, potentially attracting customers from smaller banks under competitive pressures, enhancing its market position.
- Advantages for UnitedHealth Group: As the largest health insurer, UnitedHealth Group can benefit from higher interest rates on its float, and despite potential consumer spending cuts, its valuation remains about 40% below its 2024 peak, making it more attractive to investors if Warsh successfully reduces the Fed's balance sheet.
See More
UnitedHealth Group's Earnings Outlook Remains Positive
- Strategic Transformation Success: Bank of America upgraded UnitedHealth Group from neutral to buy and raised its price target from $420 to $450, indicating a 19% upside from Wednesday's close, reflecting the initial success of the company's strategic transformation.
- Enhanced Profitability: Analysts noted that UnitedHealth's earnings power is now 50% above its 2026 outlook, which should drive share price increases, showcasing the company's successful execution in improving margins.
- Positive Market Reaction: UnitedHealth's shares rose 3% in premarket trading, and the stock has jumped nearly 26% over the past year, indicating market recognition of its strategic adjustments and future growth potential.
- Strong Analyst Consensus: Among the 30 analysts covering UnitedHealth, 23 have rated the stock as buy or strong buy, demonstrating a widespread optimistic outlook on its future performance.
See More
Bank of America Upgrades UnitedHealth to Buy Amid Positive Q2 Outlook
- Rating Upgrade: Bank of America upgraded UnitedHealth Group (UNH) from Neutral to Buy, primarily based on an optimistic outlook for Q2 earnings, indicating a resurgence of market confidence in the company.
- Improved Earnings Outlook: Analyst Kevin Fischbeck noted that UnitedHealth's strong Q1 performance was not solely due to lower medical utilization from flu and storms, but rather reflects more favorable medical cost trends, suggesting significant Q2 earnings potential.
- Price Target Increase: BofA raised its price target for UnitedHealth from $420 to $450, indicating enhanced analyst confidence in the company's future performance, which is expected to bolster its leadership position in the healthcare sector.
- Industry Influence: As a bellwether in the healthcare industry, UnitedHealth's performance is likely to impact other managed care organizations (MCOs), with analysts suggesting that if current trends persist, the company will lead its peers higher.
See More
